Dysregulation of monocytic nuclear factor-kappa B by oxidized low- density lipoprotein

Brand K, Eisele T, Kreusel U, Page M, Page S, Haas M, Gerling A, Kaltschmidt C, Neumann FJ, Mackman N, Baeuerle PA, et al. (1997)
Arterioscler. Thromb. Vasc. Biol. 17(10): 1901-1909.

Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
; ; ; ; ; ; ; ; ; ; ;
Arterioscler. Thromb. Vasc. Biol.


Brand K, Eisele T, Kreusel U, et al. Dysregulation of monocytic nuclear factor-kappa B by oxidized low- density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 1997;17(10):1901-1909.
Brand, K., Eisele, T., Kreusel, U., Page, M., Page, S., Haas, M., Gerling, A., et al. (1997). Dysregulation of monocytic nuclear factor-kappa B by oxidized low- density lipoprotein. Arterioscler. Thromb. Vasc. Biol., 17(10), 1901-1909.
Brand, K., Eisele, T., Kreusel, U., Page, M., Page, S., Haas, M., Gerling, A., Kaltschmidt, C., Neumann, F. J., Mackman, N., et al. (1997). Dysregulation of monocytic nuclear factor-kappa B by oxidized low- density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 17, 1901-1909.
Brand, K., et al., 1997. Dysregulation of monocytic nuclear factor-kappa B by oxidized low- density lipoprotein. Arterioscler. Thromb. Vasc. Biol., 17(10), p 1901-1909.
K. Brand, et al., “Dysregulation of monocytic nuclear factor-kappa B by oxidized low- density lipoprotein”, Arterioscler. Thromb. Vasc. Biol., vol. 17, 1997, pp. 1901-1909.
Brand, K., Eisele, T., Kreusel, U., Page, M., Page, S., Haas, M., Gerling, A., Kaltschmidt, C., Neumann, F.J., Mackman, N., Baeuerle, P.A., Walli, A.K., Neumeier, D.: Dysregulation of monocytic nuclear factor-kappa B by oxidized low- density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 17, 1901-1909 (1997).
Brand, K., Eisele, T., Kreusel, U., Page, M., Page, S., Haas, M., Gerling, A., Kaltschmidt, Christian, Neumann, F.J., Mackman, N., Baeuerle, P.A., Walli, A.K., and Neumeier, D. “Dysregulation of monocytic nuclear factor-kappa B by oxidized low- density lipoprotein”. Arterioscler. Thromb. Vasc. Biol. 17.10 (1997): 1901-1909.

63 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Dual signaling evoked by oxidized LDLs in vascular cells.
Nègre-Salvayre A, Augé N, Camaré C, Bacchetti T, Ferretti G, Salvayre R., Free Radic Biol Med 106(), 2017
PMID: 28189852
Defective Protein Catabolism in Atherosclerotic Vascular Inflammation.
Miyazaki T, Miyazaki A., Front Cardiovasc Med 4(), 2017
PMID: 29270409
New paradigms in inflammatory signaling in vascular endothelial cells.
Xiao L, Liu Y, Wang N., Am J Physiol Heart Circ Physiol 306(3), 2014
PMID: 24285111
The extrinsic coagulation cascade and tissue factor pathway inhibitor in macrophages: a potential therapeutic opportunity for atherosclerotic thrombosis.
Jiang P, Xue D, Zhang Y, Ye L, Liu Y, Makale M, Kesari S, Edgington TS, Liu C., Thromb Res 133(4), 2014
PMID: 24485401
Oxidized low-density lipoprotein suppresses expression of prostaglandin E receptor subtype EP3 in human THP-1 macrophages.
Sui X, Liu Y, Li Q, Liu G, Song X, Su Z, Chang X, Zhou Y, Liang B, Huang D., PLoS One 9(10), 2014
PMID: 25333975
Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment.
Nho K, Corneveaux JJ, Kim S, Lin H, Risacher SL, Shen L, Swaminathan S, Ramanan VK, Liu Y, Foroud T, Inlow MH, Siniard AL, Reiman RA, Aisen PS, Petersen RC, Green RC, Jack CR, Weiner MW, Baldwin CT, Lunetta K, Farrer LA, Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study, Furney SJ, Lovestone S, Simmons A, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, AddNeuroMed Consortium, McDonald BC, Farlow MR, Ghetti B, Indiana Memory and Aging Study, Huentelman MJ, Saykin AJ, Alzheimer's Disease Neuroimaging Initiative (ADNI)., Mol Psychiatry 18(7), 2013
PMID: 23608917
Monocytic expression of osteoclast-associated receptor (OSCAR) is induced in atherosclerotic mice and regulated by oxidized low-density lipoprotein in vitro.
Sinningen K, Rauner M, Goettsch C, Al-Fakhri N, Schoppet M, Hofbauer LC., Biochem Biophys Res Commun 437(2), 2013
PMID: 23817038
Conjugated linoleic acid isomers may diminish human macrophages adhesion to endothelial surface.
Stachowska E, Siennicka A, Baśkiewcz-Hałasa M, Bober J, Machalinski B, Chlubek D., Int J Food Sci Nutr 63(1), 2012
PMID: 21721848
OxLDL inhibits LPS-induced IFNβ expression by Pellino3- and IRAK1/4-dependent modification of TANK.
Tzieply N, Kuhn AM, Morbitzer D, Namgaladze D, Heeg A, Schaefer L, von Knethen A, Jensen LE, Brüne B., Cell Signal 24(6), 2012
PMID: 22330071
Myeloid IκBα deficiency promotes atherogenesis by enhancing leukocyte recruitment to the plaques.
Goossens P, Vergouwe MN, Gijbels MJ, Curfs DM, van Woezik JH, Hoeksema MA, Xanthoulea S, Leenen PJ, Rupec RA, Hofker MH, de Winther MP., PLoS One 6(7), 2011
PMID: 21814576
Comparison of anti-atherosclerotic effects of two different extracts from leaves of Mallotus furetianus.
Yueli L, Liqun W, Haitao W, Lianbo L, Xinan Y., Asian Pac J Trop Med 4(11), 2011
PMID: 22078950
oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation.
Nickel T, Schmauss D, Hanssen H, Sicic Z, Krebs B, Jankl S, Summo C, Fraunberger P, Walli AK, Pfeiler S, Weis M., Atherosclerosis 205(2), 2009
PMID: 19203752
Low vasa vasorum densities correlate with inflammation and subintimal thickening: potential role in location--determination of atherogenesis.
Gössl M, Versari D, Lerman LO, Chade AR, Beighley PE, Erbel R, Ritman EL., Atherosclerosis 206(2), 2009
PMID: 19368925
Increased tissue transglutaminase expression in human atherosclerotic coronary arteries.
Cho BR, Kim MK, Suh DH, Hahn JH, Lee BG, Choi YC, Kwon TJ, Kim SY, Kim DJ., Coron Artery Dis 19(7), 2008
PMID: 18923241
High tissue factor-expressing human monocytes carry low surface CD36: application to intersubject variability.
Sovershaev MA, Egorina EM, Gruber FX, Olsen JO, Osterud B., J Thromb Haemost 5(12), 2007
PMID: 17900273
Adriamycin promotes macrophage dysfunction in mice.
Asmis R, Qiao M, Rossi RR, Cholewa J, Xu L, Asmis LM., Free Radic Biol Med 41(1), 2006
PMID: 16781464
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs.
Zardi EM, Zardi DM, Cacciapaglia F, Dobrina A, Amoroso A, Picardi A, Afeltra A., Int Immunopharmacol 5(3), 2005
PMID: 15683843
Enhanced plasma levels of oxidized low-density lipoprotein increase circulating nuclear factor-kappa B activation in patients with unstable angina.
Cominacini L, Anselmi M, Garbin U, Fratta Pasini A, Stranieri C, Fusaro M, Nava C, Agostoni P, Keta D, Zardini P, Sawamura T, Lo Cascio V., J Am Coll Cardiol 46(5), 2005
PMID: 16139128
Dual role of oxidized LDL on the NF-kappaB signaling pathway.
Robbesyn F, Salvayre R, Negre-Salvayre A., Free Radic Res 38(6), 2004
PMID: 15346645
Role of vasa vasorum in transendothelial solute transport in the coronary vessel wall: a study with cryostatic micro-CT.
Gössl M, Beighley PE, Malyar NM, Ritman EL., Am J Physiol Heart Circ Physiol 287(5), 2004
PMID: 15178545
Involvement of NF-kappaB signalling in skin physiology and disease.
Bell S, Degitz K, Quirling M, Jilg N, Page S, Brand K., Cell Signal 15(1), 2003
PMID: 12401514
Hematein inhibits atherosclerosis by inhibition of reactive oxygen generation and NF-kappaB-dependent inflammatory mediators in hyperlipidemic mice.
Choi JH, Jeong TS, Kim DY, Kim YM, Na HJ, Nam KH, Lee SB, Kim HC, Oh SR, Choi YK, Bok SH, Oh GT., J Cardiovasc Pharmacol 42(2), 2003
PMID: 12883334
Anti-inflammatory properties of lipid oxidation products.
Bochkov VN, Leitinger N., J Mol Med (Berl) 81(10), 2003
PMID: 13679995
Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent.
Mempel M, Voelcker V, Köllisch G, Plank C, Rad R, Gerhard M, Schnopp C, Fraunberger P, Walli AK, Ring J, Abeck D, Ollert M., J Invest Dermatol 121(6), 2003
PMID: 14675188
The role of chemokines in human cardiovascular pathology: enhanced biological insights.
Shin WS, Szuba A, Rockson SG., Atherosclerosis 160(1), 2002
PMID: 11755926
Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris.
Wilson SH, Best PJ, Edwards WD, Holmes DR, Carlson PJ, Celermajer DS, Lerman A., Atherosclerosis 160(1), 2002
PMID: 11755932
Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts.
Baumgartner B, Weber M, Quirling M, Fischer C, Page S, Adam M, Von Schilling C, Waterhouse C, Schmid C, Neumeier D, Brand K., Leukemia 16(10), 2002
PMID: 12357358
Decreased inducibility of TNF expression in lipid-loaded macrophages.
Ares MP, Stollenwerk M, Olsson A, Kallin B, Jovinge S, Nilsson J., BMC Immunol 3(), 2002
PMID: 12366867
Chlamydia pneumoniae activates IKK/I kappa B-mediated signaling, which is inhibited by 4-HNE and following primary exposure.
Donath B, Fischer C, Page S, Prebeck S, Jilg N, Weber M, da Costa C, Neumeier D, Miethke T, Brand K., Atherosclerosis 165(1), 2002
PMID: 12208473
Oxidized low-density lipoprotein-induced apoptosis.
Salvayre R, Auge N, Benoist H, Negre-Salvayre A., Biochim Biophys Acta 1585(2-3), 2002
PMID: 12531556
Effect of hypercholesterolemia on macrophage infiltration after balloon injury to rabbit iliac artery.
Song JM, Kim HS, Park SJ, Chae IH, Oh BH, Lee MM, Park YB., Jpn Circ J 65(2), 2001
PMID: 11216820
NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?
Collins T, Cybulsky MI., J Clin Invest 107(3), 2001
PMID: 11160146
[Cellular and molecular biology of atherosclerotic lesions]
Martínez-González J, Llorente-Cortés V, Badimon L., Rev Esp Cardiol 54(2), 2001
PMID: 11181311
Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36.
Guy RA, Maguire GF, Crandall I, Connelly PW, Kain KC., Atherosclerosis 155(1), 2001
PMID: 11223422
t-Butyl hydroperoxide and oxidized low density lipoprotein enhance phospholipid hydrolysis in lipopolysaccharide-stimulated retinal pericytes.
Lupo G, Anfuso CD, Ragusa N, Strosznajder RP, Walski M, Alberghina M., Biochim Biophys Acta 1531(1-2), 2001
PMID: 11278179
The effect of endothelin-1 on nuclear factor kappa B in macrophages.
Wilson SH, Simari RD, Lerman A., Biochem Biophys Res Commun 286(5), 2001
PMID: 11527395
Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia.
Wilson SH, Caplice NM, Simari RD, Holmes DR, Carlson PJ, Lerman A., Atherosclerosis 148(1), 2000
PMID: 10580167
Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis.
Gawaz M, Brand K, Dickfeld T, Pogatsa-Murray G, Page S, Bogner C, Koch W, Schömig A, Neumann F., Atherosclerosis 148(1), 2000
PMID: 10580173
Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: potential role in oxidized LDL-induced apoptosis.
Vieira O, Escargueil-Blanc I, Jürgens G, Borner C, Almeida L, Salvayre R, Nègre-Salvayre A., FASEB J 14(3), 2000
PMID: 10698969
Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner.
Delerive P, Furman C, Teissier E, Fruchart J, Duriez P, Staels B., FEBS Lett 471(1), 2000
PMID: 10760508
Role of reactive aldehyde in cardiovascular diseases.
Uchida K., Free Radic Biol Med 28(12), 2000
PMID: 10946210
A model to study antioxidant regulation of endotoxemia-modulated neonatal granulopoiesis and granulocyte apoptosis.
Yang KD, Chen MZ, Teng RJ, Yang MY, Liu HC, Chen RF, Hsu TY, Shaio MF., Pediatr Res 48(6), 2000
PMID: 11102554
Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes.
Caspar-Bauguil S, Tkaczuk J, Haure MJ, Durand M, Alcouffe J, Thomsen M, Salvayre R, Benoist H., Biochem J 337 ( Pt 2)(), 1999
PMID: 9882624
Involvement of nuclear factor-kappaB in a murine model for the acute form of autoimmune-like toxic oil syndrome.
Bell SA, Page S, Baumgartner B, Berking C, Haas M, Eisele T, Neumeier D, Brand K., Toxicol Appl Pharmacol 157(3), 1999
PMID: 10373405
Chemokines and atherosclerosis.
Terkeltaub R, Boisvert WA, Curtiss LK., Curr Opin Lipidol 9(5), 1998
PMID: 9812193


Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®


PMID: 9351352
PubMed | Europe PMC

Suchen in

Google Scholar